Patients with schizophrenia not only suffer from severe psychological symptoms, but also have a dramatically increased risk of cardiometabolic diseases. The interplay of disease-associated mechanisms, genetic predispositions and exogenous influences leads to the development of a metabolic syndrome in many patients, which significantly increases morbidity and mortality.
You May Also Like
- Progressive multiple sclerosis
New horizons: from BTK inhibitors to remyelination
- Cutaneous and especially facial metastases
Rare manifestations of esophageal carcinoma
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- IMCAS Refresher: Aging Sciences/Plastic Surgery
Trends in aesthetic and regenerative medicine
- Pelargonium sidoides
Scoping review sheds light on the multifaceted spectrum of effects
- New evidence on genetics, pathophysiology and clinical significance
Migraine with and without aura – two different entities?
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Case report: L. pneumophila pneumonia